Sweden’s Amferia secures €1.2M to kill bacteria, even resistant ones; here’s how
Mölndal-based Amferia, a Swedish medtech company specialising in antimicrobial healthcare solutions, has completed an “over-prescribed” €1.2M investment round, with participation from existing owners, new investors, and Chalmers Ventures.